Clinical trial
rhGH Therapy on Hepatic Drug Metabolism
NCT00458991 · University of Louisville, Other · Completed
Key facts
| NCT number | NCT00458991 |
|---|---|
| Title | rhGH Therapy on Hepatic Drug Metabolism |
| Official title | Recombinant Human Growth Hormone Therapy and Drug Metabolism |
| Lead sponsor | University of Louisville, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Growth Hormone Deficiency, Dwarfism |
| Intervention type | Drug |
| Interventions | Dextromethorphan and Caffeine |
| Enrollment | 9 |
| Start date | Jun 1, 2001 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 11, 2007 |
| Last update posted | Apr 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: